Positive Partial 12-Week Blood Sugar Results from Lexaria’s GLP-1 Diabetes Animal Study
DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing blood sugar groups KELOWNA, BC / ...
Positive Partial 12-Week Body Weight Results from Lexaria’s GLP-1 Diabetes Animal Study
DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing weight loss groups Accelerated rates ...
T-Net7d
Kelowna-based Lexaria Closes $5 Million Financing via Private Placement (Registered Direct Offering)
Bioscience Corp. (Nasdaq:LEXX; LEXXW), a developer of drug delivery platforms, today announced that it has closed a ...
Investing15d
Lexaria starts pilot study for oral diabetes treatment
KELOWNA, British Columbia - Lexaria Bioscience (NASDAQ:LEXX) Corp. (NASDAQ:LEXX, LEXXW), a drug delivery platform innovator, has commenced a human pilot study to assess an oral dosage form of the ...
PharmiWeb15d
Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing
DehydraTECH-processed tirzepatide from Zepbound® is being tested in an oral dose format KELOWNA, BC / ACCESSWIRE / October 9, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" ...
Investing15d
Lexaria starts pilot study for oral diabetes treatment
KELOWNA, British Columbia - Lexaria Bioscience (NASDAQ:LEXX) Corp. (NASDAQ:LEXX, LEXXW), a drug delivery platform innovator, has commenced a human pilot study to assess an oral dosage form of the ...